Transaction #13008 · Form 4 · 0001205069-25-000007
AtriCure, Inc. · Exercise / conversion · Common Stock
AtriCure, Inc. · Transacted November 24, 2025 · Filed November 26, 2025
What does this filing report?
An SEC Form 4 filing for AtriCure, Inc. records an exercise / conversion involving Common Stock on November 24, 2025. The reported quantity was 5,033. The filing date is November 26, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- AtriCure, Inc.
- Company CIK
- 0001323885
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 5,033
- Reported price
- 19.95
- Reference value
- 100,408.35
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 39,407
- Ownership description
- Not reported
- SEC acceptance time
- Nov 26, 2025, 4:43 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- WEHRWEIN SVEN ↗
Director
CIK 0001205069
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This transaction was executed in multiple trades at prices ranging from $37.32 to $38.00 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2
- These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.